TY  - GEN
AU  - Prada,Nicole
AU  - Davis,Brandi
AU  - Jean-Pierre,Patrick
AU  - La Roche,Matthew
AU  - Duh,Fuh-Mei
AU  - Carrington,Mary
AU  - Poles,Michael
AU  - Mehandru,Saurabh
AU  - Mohri,Hiroshi
AU  - Markowitz,Martin
TI  - Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course
SN  - 1525-4135
PY  - 2008///1031
KW  - Adenine
KW  - analogs & derivatives
KW  - Adult
KW  - Amino Acid Sequence
KW  - Anti-HIV Agents
KW  - therapeutic use
KW  - CD4 Lymphocyte Count
KW  - Chemoprevention
KW  - methods
KW  - Deoxycytidine
KW  - Drug Resistance, Viral
KW  - Emtricitabine
KW  - Genotype
KW  - HIV Infections
KW  - physiopathology
KW  - HIV Reverse Transcriptase
KW  - genetics
KW  - HIV Seropositivity
KW  - HIV-1
KW  - HLA Antigens
KW  - Humans
KW  - Intestinal Mucosa
KW  - immunology
KW  - Male
KW  - Microbial Sensitivity Tests
KW  - Molecular Sequence Data
KW  - Organophosphonates
KW  - Phylogeny
KW  - Receptors, CCR5
KW  - Sequence Alignment
KW  - Tenofovir
KW  - Time Factors
KW  - Viral Load
KW  - Viremia
N1  - Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1097/QAI.0b013e3181869a9b
ER  -